UHF Alberta and Servier logo

Servier Alberta Innovation in Health Fund (SAIHF)

The Servier Alberta Innovation in Health Fund (SAIHF) is a $1.7 million fund focused on fostering and accelerating research and health innovation in four areas of healthcare – cardiac sciences, diabetes, neurology and oncology.

A Private Public Philanthropic Partnership between Servier Canada Inc.- the Canadian affiliate of The Servier Research Group - the Government of Alberta’s Ministry of Economic Development and Trade and the Unviersity Hospital Foundation, the fund supports health care research and innovation.

Representatives from UHF, Alberta and Servier

Partnership Focus Areas

This partnership builds on Servier's first investment in the University Hospital Foundation, a $1 million fund that led to the opening in 2014 of the Servier Virtual Cardiac Centre at the Mazankowski Alberta Heart Institute, the first of its kind in Canada, bringing together teams in stroke care, heart failure, oncology and data analytics. 

Research Impact

A call for Letters of Interest (LOI) for research and innovation projects in cardiology closed on June 9, 2017, with twenty-two LOIs received from across Alberta. On February 15, 2018, Servier Canada, the Government of Alberta and the University Hospital Foundation announced the funding of three inaugural research projects within SAIHF:

  • Dr. Nowell Fine and Dr. Justin Ezekowitz - Using machine-learning techniques to predict heart failure hospital readmissions in Alberta: A province-wide derivation and validation study
  • Dr. Ross Tsuyuki - A Population Approach to Improving Hypertension Management in the Community Using Pharmacists’ Advanced Scope of Practice in Alberta – A Cluster Randomized Trial of the Hypertension Canada Professional Designation Program
  • Dr. Ken Butcher - LASER (Lixiana Acute Stroke Evaluation Registry)

In addition to the research fund recipients, the SAIHF fund will  support Servier Alberta Advanced Heart Failure Scholar at the Libin Cardiovascular Institute. 

About Servier

Servier is an international pharmaceutical company governed by a non-profit foundation with its headquarters in Suresnes (France). With a strong international presence in 148 countries, Servier employs 21 000 people worldwide. Corporate growth is driven by Servier’s constant search for innovation in five areas of excellence: cardiovascular diseases, diabetes, cancers, immune-inflammatory diseases, and neurodegenerative diseases. Being completely independent, the Group reinvests 25% of turnover in research and development and uses all its profits for growth.

Servier Canada was established in 1978 in Laval, Quebec and employs over 320 people across Canada. Servier Canada is currently marketing medicines in Cardiology, Hematology and Diabetes, and will soon market oncology products indicated as treatment options in hematological malignancies. For additional information please visit our website at www.servier.ca

About Alberta Economic Development and Trade

The Ministry of Alberta Economic Development and Trade focuses on economic growth and diversification by supporting innovation and research; expanding access to capital for small and medium-sized enterprises; promoting trade, investment and market access initiatives; and leading Alberta’s negotiations on trade agreements. Learn more at http://economic.alberta.ca.

Donor Office - University of Alberta Hospital

1H1.91 WMC, 8440 – 112 Street NW, Edmonton, AB T6G 2B7

Donor Office - Mazankowski Alberta Heart Institute

2A9.006 MAHI, 8440 – 112 Street NW, Edmonton, AB T6G 2B7

Donor Office - Kaye Edmonton Clinic

1B.120 KEC, 11400 University Avenue, Edmonton, AB T6G 1Z1

University Hospital Foundation

Phone: 780-407-7007 | Fax: 780-407-6603
Charitable Registration Number  88900-3240 RR0001


     AHP High Performer 2017     



Copyright 2020 University Hospital Foundation